By Vinicy Chan Bloomberg Manuel Baigorri Thu., April 4, 2019 Apotex Inc. is exploring a sale as some major pharmaceutical companies and investors expressed interest in the closely held Canadian drugmaker, according to people familiar with the matter. Apotex is working with a financial adviser as it reviews options that may lead to a partial or full sale of the business, the people said. A sale of the whole company could fetch about $3 billion (U.S.), the people said, asking not to be identified because the deliberations are private. Sale considerations are preliminary and no final decision has been made on the details of the deal including its structure, the people said. A representative for Ontario-based Apotex didn’t respond to requests for comment. Founded in 1974, Apotex makes generic and innovative drugs and operates in more than 45 countries including the U.S., Mexico and India, according to its website. Last year, Apotex agreed to sell its commercial … [Read more...] about Canadian drugmaker Apotex weighs sale amid interest
Indias top 10 pharma companies
WASHINGTON/NEW DELHI (Reuters) - U.S. President Donald Trump looked set to open a new front in his trade wars on Monday with a plan to end preferential trade treatment for India that allows duty-free entry for up to $5.6 billion worth of its exports to the United States. FILE PHOTO: U.S. President Donald Trump holds a bilateral meeting with India's Prime Minister Narendra Modi alongside the ASEAN Summit in Manila, Philippines November 13, 2017. REUTERS/Jonathan Ernst/File Photo India played down the impact, saying it was keeping retaliatory tariffs out of its talks with the United States, but the opposition could seize on the issue to embarrass Prime Minister Narendra Modi ahead of general elections this year. Trump, who has vowed to cut U.S. trade deficits, has repeatedly called out India for its high tariffs, and U.S. trade officials said scrapping the concessions would take at least 60 days after notifications to Congress and the Indian government. “I am taking this … [Read more...] about Trump scraps trade privilege for India; Delhi plays down impact
Sections SEARCH Skip to content Skip to site index Log In Subscribe Log In Today’s Paper DealBook | DealBook Briefing: The Fed’s Reversal Soothes Wall St. DealBook Supported by Jan. 31, 2019 Good Thursday morning. (Was this email forwarded to you? Sign up here .) A surprise shift from the Federal Reserve In a sharp reversal of the stance it took just week ago, the Fed’s chairman, Jerome Powell, said yesterday it had “the luxury of patience” in deciding whether to raise rates again, writes the NYT’s Binyamin Appelbaum. The news: The Fed left its benchmark interest rate unchanged, a decision that was widely expected. What surprised markets was the indication that rates, which are in a range of 2.25 percent to 2.5 percent, would stay put for some time. The reaction: Mr. Powell’s comments soothed Wall Street, sending stocks higher, something President Trump cheered on Twitter. … [Read more...] about DealBook Briefing: The Fed’s Reversal Soothes Wall St.
Visit The Boston Globe Share on Twitter Share on Facebook Comment on this Scroll to top of page Jonathan Saltzman and Maria Cramer Globe Staff January 28, 2019 The federal government, which has been accused of failing to hold drug companies to account for the nation’s deadly opioid epidemic, hopes to dispel that impression Monday when the first criminal trial of pharmaceutical executives who marketed a painkiller begins.John N. Kapoor, a onetime billionaire andfounder of Arizona-based Insys Therapeutics, is scheduled to go on trial in US District Court in Boston along with four former company executives on charges that they acted more like mobsters than pharmaceutical executives when they sold a brand of fentanyl, a powerful and addictive opioid.In a trial expected to last up to three months, federal prosecutors will try to convince a jury that the five defendants paid bribes and kickbacks to physicians in a nationwide racketeering conspiracy. The … [Read more...] about Opioid company executives set to go on trial in Boston Monday
EVFTA opens new era in Vietnam-EU trade ties: Italian experts The factory of the Far Eastern New Apparel Vietnam company in Bac Dong Phu Industrial Park, Binh Phuoc province The EU-Vietnam Free Trade Agreement (EVFTA) is hoped to usher in a new period in promoting cooperation and mutual economic development between the two sides as it comes into effect in mid-2019, according to Italian experts. In a recent interview granted to Vietnam News Agency’s correspondent in Italy, Vietnam’s Honorary Consul in Turin Sandra Scagliotti and Chairman of the Italy-Vietnam Chamber of Commerce Fulvio Albano stressed that the new-generation agreement may mark the beginning of a new era in trade relations between Vietnam and the EU. Negotiations and the legal review have been completed for both the free trade agreement and the one on investment protection. The EVFTA process is now awaiting the Council of Europe and the European Parliament to sign and ratify it. The agreement … [Read more...] about BUSINESS NEWS IN BRIEF 22/1